Inhibition of cytochrome P-450 modulates all-trans-retinoic acid-induced differentiation and apoptosis of HL-60 cells

Cancer Detection and Prevention

Volumn 24, Issue 4, 2000, Pages 325-342

  Hofmanova, J ^a   Soucek, K ^a   Dusek, L ^a   Netikova, J ^a   Kozubik, A ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Bcl 2 protein; Cell cycle; Dimethyl sulfoxide; Myeloid leukemia; Proadifen; SKF525A

Indexed keywords

CYTOCHROME P 450 ENZYME SYSTEM; CYTOCHROME P450; DIMETHYL SULFOXIDE; ONCOPROTEIN; PROADIFEN; PROTO ONCOGENE PROTEINS C BCL 2; RETINOIC ACID;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN HL 60; DOSE RESPONSE; DOWN REGULATION; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; FLOW CYTOMETRY; HUMAN; METABOLISM; NONPARAMETRIC TEST; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; APOPTOSIS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG COMBINATIONS; DRUG SYNERGISM; DRUG TOLERANCE; FLOW CYTOMETRY; HL-60 CELLS; HUMAN; PROADIFEN; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; TRETINOIN;

EID: 0033784489     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
2. Acute promyelocytic leukemia: A paradigm for differentiation therapy with retinoic acid
3. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acids
4. Functional characteristics of mature granulocytes in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid
5. Acute promyelocytic leukemia
6. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia
7. The 'retinoic acid syndrome' in acute promyelocytic leukemia
8. Constitutive variability in the pharmacokinetics of the natural retlnoid, all-trans-retinoic acid, and its modulation by ketoconazole
9. Highly specific cytochrome P450-like enzymes for all-trans-retinoic acid in T47D human breast cancer cells
10. Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cells
11. Effect of cytochrome P-450 inhibitors on the in vivo metabolism of all- trans-retinoic acid in rats
12. Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P450 and P-glycoprotein
13. Liarozole potentiates the all-trans-retinoic acid-induced structural remodeling in human breast carcinoma MCF-7 cells in vitro
14. Enhancement of antiproliferative activity of 1α,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific
15. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis
16. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation
17. Cell death in myeloid lineage
18. Analysis of the role of bcl-2 in apoptosis
19. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells
20. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells
21. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes
22. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells
23. Comparison of the effects of inhibitors of cytochrome P-450-mediated reactions on human platelet aggregation and arachidonic acid metabolism
24. Microfluorometric analysis of nuclear DNA in cells from tumors and cell suspension
25. Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3
26. P450-dependent enzymes as targets for prostate cancer therapy
27. Clinical pharmacology of all-trans retinoic acid
28. Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms
29. 5-Lipoxygenase inhibitors potentiate effects of TGF-β 1 on the differentiation of human leukemia HL-60 cells
30. Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells
31. Cytochrome P-450 metabolism of arachidonic acid: Formation and biological actions of 'epoxygenase'-derived eicosanoids
32. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells
33. Involvement of an arachidonic-acid-dependent pathway in the interferon-β mediated expression of C202 gene in Ehrlich-ascites-tumor cells
34. Evolutionary argument for a connection between drug metabolism and signal transduction
35. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions
36. Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: Possible relationship to NF-kB
37. Growth of single HL60 Cells in liquid culture: Analysis of the influences of differentiative agents
38. A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: Implications of RARalfa-mediated signals in myeloid leukemic cells
39. P450 inhibitors of use in medical treatment: Focus on mechanisms of action